Logo for AC Immune SA

AC Immune Investor Relations Material

Latest events

Logo for AC Immune

AGM 2024 Presentation

20 Jun, 2024
Logo for AC Immune

Q1 2024

13 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from AC Immune SA

Access all reports
AC Immune SA is a clinical-stage biopharmaceutical company that specializes in precision medicine for neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and NeuroOrphan diseases. These candidates target the misfolded proteins associated with these diseases, aiming to diagnose, treat, and prevent neurodegeneration. AC Immune SA is headquartered in Lausanne, Switzerland, and its shares are listed on the Nasdaq.